Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours.
about
Stathmin potentiates vinflunine and inhibits Paclitaxel activityStathmin regulates centrosomal nucleation of microtubules and tubulin dimer/polymer partitioning.Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment.Gene expression profiles in mouse embryo fibroblasts lacking stathmin, a microtubule regulatory protein, reveal changes in the expression of genes contributing to cell motility.Mechanisms of Taxol resistance related to microtubules.Stathmin/Op18 is a novel mediator of vinblastine activity.Increased expression of stathmin and elongation factor 1α in precancerous nodules with telomere dysfunction in hepatitis B viral cirrhotic patients.A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresis.Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanomaP18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxaneAnti-centrosome antibodies in breast cancer are the expression of autoimmunity.Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer.Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancerRegulation of Op18 during spindle assembly in Xenopus egg extracts.Stathmin is involved in the cooperative effect of Zoledronic acid and gefitinib on bone homing breast cancer cells in vitro.Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivoComparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysisFunctional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapyThe cytotoxic effect of memantine and its effect on cytoskeletal proteins expression in metastatic breast cancer cell line.Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis.Stathmin: a protein with many tasks. New biomarker and potential target in cancer.Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.Rac1 and Stathmin but Not EB1 Are Required for Invasion of Breast Cancer Cells in Response to IGF-I.Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer.Epstein-Barr virus-encoded LMP1 triggers regulation of the ERK-mediated Op18/stathmin signaling pathway in association with cell cycle.Phospho-Network Analysis Identifies and Quantifies Hepatitis C Virus (HCV)-induced Hepatocellular Carcinoma (HCC) Proteins Regulating Viral-mediated Tumor GrowthEffects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells.Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53.Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells.Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.A synergistic relationship between three regions of stathmin family proteins is required for the formation of a stable complex with tubulin.c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18.
P2860
Q28547666-7B4DC4CF-F665-499F-9C12-22A5A1E4AD25Q30489220-0818A418-F9E8-4161-B16E-8E7291029AF2Q33224181-5FF6E115-B7E6-49AE-BAD8-4ED29251BDB2Q33288665-2AD62D1D-9144-4A69-8278-64813C63FC92Q33488716-2FA4B12B-91D1-483F-B66E-33C3480E8C85Q33688044-92BF0A2A-2A0A-479B-A611-75426D52953AQ33723823-BDAE4FF1-5152-464C-91D6-C459770E9C8EQ33728805-59D16C2A-3BB1-4B94-BC57-AF0E9F405304Q33837712-C8D32FF9-363C-48A3-B87A-5BE9159F0DF4Q34350615-0070162D-5500-44B8-93B5-688624E941DEQ34446981-5FFE95B9-0200-4AF4-855D-FE18060552D3Q34472289-7593EE4A-AE44-4631-A0F1-A53A0E2ED316Q35083873-365EC262-1FF9-4A44-B962-961257DB5DCCQ35376227-6B7E2EB7-1AE5-49DD-9E53-464A354DA8E7Q35446906-E9BD47A7-AF58-45C1-ACFE-B7DC82B1457DQ35757521-DB141D32-3DC1-4800-870C-B1AA226007C1Q36080919-A3FC616B-943E-4913-8FCE-7ABAAC09CF61Q36277733-87F2D128-B4B2-4123-8256-9F8491EEEDBDQ36342416-4C337F34-4CD5-4F71-8104-BBD1BC3DBF13Q36491391-6F0B88DD-3477-47A8-AEA3-56A77F19F54AQ36631230-577989B1-F4C3-4F4A-B3A8-D8040D963770Q37044488-69E80274-AE40-4B78-A004-681597DE73ADQ37171613-18272CE9-F71C-424F-B932-A9E589369A34Q37200505-2DA6E268-391B-4F94-A70F-13293E03A332Q37592867-7CA3E771-CB77-4CAD-8808-ACF0E210D2E7Q37694739-659C2D06-19BC-45B1-95F3-8D15F6A34BF6Q37942978-35274911-5E7D-4BFD-9AF7-D607EDDE48A7Q38387283-B42D23C3-693E-4F25-8687-3E42CB765F1DQ38561479-70B19374-0B20-4BED-8D7A-D183402CD0A1Q38568602-3D8E2844-AAA0-44DF-BC33-B2E8A053941EQ39160331-BE2C5A5D-B38D-4A83-BCBC-134103270B6DQ39379903-21D4E756-E69B-4A54-A048-07174599D5C4Q39448686-5E4CEA68-1C4D-49DD-BC40-B76C97F65D19Q39747031-814B2FBB-288E-4127-B6DF-135E37CF0321Q40243704-0F132F53-D9CA-47C3-9465-40B201080C5EQ40610736-83940B09-21D9-454A-96AE-69279B8F9AEDQ41469992-9475BDA3-A109-4B50-A740-7246B7490C54Q41908449-095A580E-7FA4-4835-93DD-56B7AE7D7259Q42473635-C532D2B3-8B1B-40E4-A036-6546DF52E3B2
P2860
Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Overexpression of stathmin in ...... highly proliferative tumours.
@ast
Overexpression of stathmin in ...... highly proliferative tumours.
@en
type
label
Overexpression of stathmin in ...... highly proliferative tumours.
@ast
Overexpression of stathmin in ...... highly proliferative tumours.
@en
prefLabel
Overexpression of stathmin in ...... highly proliferative tumours.
@ast
Overexpression of stathmin in ...... highly proliferative tumours.
@en
P2093
P2860
P356
P1476
Overexpression of stathmin in ...... highly proliferative tumours.
@en
P2093
Gonthier MP
Lidereau R
P2860
P2888
P304
P356
10.1054/BJOC.1999.0891
P407
P577
2000-01-01T00:00:00Z
P5875
P6179
1028282791